[EXPERIMENTAL STUDY OF THE TREATMENT OF TOXOPLASMOSIS].
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D003091:Colistin; D007612:Kanamycin; D051379:Mice; D009827:Oleandomycin; D010118:Oxytetracycline; D010404:Penicillin V; D010406:Penicillins; D010600:Pharmacology; D011739:Pyrimethamine; D012106:Research; D012294:Rifamycins; D015572:Spiramycin; D013411:Sulfadiazine; D013752:Tetracycline; D013754:Tetracyclines; D014123:Toxoplasmosis
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D010406:Penicillins; D012294:Rifamycins; D013754:Tetracyclines; D013411:Sulfadiazine; C005470:penimepicycline; D007612:Kanamycin; D015572:Spiramycin; C023808:rifamycin SV; D013752:Tetracycline; D009827:Oleandomycin; D010118:Oxytetracycline; D011739:Pyrimethamine; D010404:Penicillin V; D003091:Colistin
ANTIBIOTICS; ANTIFUNGAL AGENTS; COLISTIN; EXPERIMENTAL LAB STUDY; KANAMYCIN; MICE; OLEANDOMYCIN; OXYTETRACYCLINE; PENICILLIN; PENIMEPICYCLINE; PHARMACOLOGY; PYRIMETHAMINE; RIFOMYCIN; SPIRAMYCIN; SULFADIAZINE; TETRACYCLINE
ETUDE EXP'ERIMENTALE DU TRAITEMENT DE LA TOXOPLASMOSE.